Utility of Clinical-Pathological Parameters for Exclusion of BRCA1/2 Mutation Carriers as Candidates for Partial Breast Irradiation
-
Published:2024-09
Issue:5
Volume:14
Page:435-442
-
ISSN:1879-8500
-
Container-title:Practical Radiation Oncology
-
language:en
-
Short-container-title:Practical Radiation Oncology
Author:
Bernstein-Molho Rinat,
Abu-Shehada Narmeen,
Gal-Yam Einav Nili,
Zippel Douglas,
Menes Tehillah,
Sklair-Levy Miri,
Galper Shira,
Kaidar-Person OritORCID
Reference35 articles.
1. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis;Yoshida;Breast Cancer,2021
2. Hereditary breast cancer: clinical, pathological and molecular characteristics;Larsen;Breast Cancer (Auckl),2014
3. European Breast Cancer Council manifesto 2018: genetic risk prediction testing in breast cancer;Rutgers;Eur J Cancer,2019
4. A population-based study of genes previously implicated in breast cancer;Hu;N Engl J Med,2021
5. Breast cancer risk genes – association analysis in more than 113,000 women;Dorling;N Engl J Med,2021